Using an EGFR inhibitor in addition to SN-38 may possibly defeat resistance by increasing tumor cell apoptosis [26] and one study has confirmed the efficacy of chemoembolization with irinotecan in combination with anti-EGFR antibody therapy (cetuximab) [27]. This evidence concerns the gene EGFR and neoplasm.